Malaria Infection as a Treatment for Lung Cancer
Author Information
Author(s): Chen Lili, He Zhengxiang, Qin Li, Li Qinyan, Shi Xibao, Zhao Siting, Chen Ling, Zhong Nanshan, Chen Xiaoping
Primary Institution: Center for Infection and Immunity, State Key Laboratory of Respiratory Disease, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China
Hypothesis
Malaria parasite infection is therapeutic for lung cancer.
Conclusion
Malaria infection significantly suppresses lung cancer growth and metastasis by inducing both innate and adaptive immune responses.
Supporting Evidence
- Malaria infection inhibited tumor growth and metastasis in mice.
- Histological analysis showed decreased tumor cell proliferation and increased apoptosis.
- Malaria infection enhanced the immune response against lung cancer DNA vaccine.
Takeaway
Infected mice with malaria showed less tumor growth and lived longer, suggesting that malaria might help fight lung cancer.
Methodology
The study examined the antitumor effect of malaria infection in murine Lewis lung cancer models through various assays including tumor growth measurement and immune response analysis.
Limitations
The study's findings may not fully translate to humans due to differences in malaria infection dynamics and the absence of fever in rodent models.
Participant Demographics
Female 8- to 10-week-old C57BL/6 mice were used in the study.
Statistical Information
P-Value
p<0.0001
Statistical Significance
p<0.0001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website